[HTML][HTML] Current management of autosomal dominant polycystic kidney disease
JA Akoh - World journal of nephrology, 2015 - ncbi.nlm.nih.gov
Autosomal dominant polycystic kidney disease (ADPKD), the most frequent cause of genetic
renal disease affecting approximately 4 to 7 million individuals worldwide and accounting for …
renal disease affecting approximately 4 to 7 million individuals worldwide and accounting for …
[HTML][HTML] Somatostatin analog therapy effectiveness on the progression of polycystic kidney and liver disease: a systematic review and meta-analysis of randomized …
T Suwabe, FJ Barrera, R Rodriguez-Gutierrez… - PLoS …, 2021 - journals.plos.org
Background Uncertainty underlies the effectiveness of somatostatin analogues for slowing
the progression of polycystic kidney or liver disease. Methods Eligible studies included …
the progression of polycystic kidney or liver disease. Methods Eligible studies included …
[HTML][HTML] Tolvaptan and kidney pain in patients with autosomal dominant polycystic kidney disease: secondary analysis from a randomized controlled trial
NF Casteleijn, JD Blais, AB Chapman… - American Journal of …, 2017 - Elsevier
Background Kidney pain is a common complication in patients with autosomal dominant
polycystic kidney disease (ADPKD), and data from the TEMPO 3: 4 trial suggested that …
polycystic kidney disease (ADPKD), and data from the TEMPO 3: 4 trial suggested that …
[HTML][HTML] Clinical correlates of mass effect in autosomal dominant polycystic kidney disease
H Kim, HC Park, H Ryu, K Kim, HS Kim, KH Oh, SJ Yu… - PloS one, 2015 - journals.plos.org
Mass effect from polycystic kidney and liver enlargement can result in significant clinical
complications and symptoms in autosomal dominant polycystic kidney disease (ADPKD). In …
complications and symptoms in autosomal dominant polycystic kidney disease (ADPKD). In …
Increased psychosocial risk, depression and reduced quality of life living with autosomal dominant polycystic kidney disease
RJ Simms, KM Thong, GC Dworschak… - Nephrology Dialysis …, 2016 - academic.oup.com
Background The psychosocial impact of living with autosomal dominant polycystic kidney
disease (ADPKD) is poorly understood. In this study, we assessed the overall quality of life …
disease (ADPKD) is poorly understood. In this study, we assessed the overall quality of life …
A painful inheritance—patient perspectives on living with polycystic kidney disease: thematic synthesis of qualitative research
Background Autosomal dominant polycystic kidney disease (ADPKD) is a life-threatening
genetic disorder and has multiple complications including, infection, pain, intracranial …
genetic disorder and has multiple complications including, infection, pain, intracranial …
[HTML][HTML] Quality of life in autosomal dominant polycystic kidney disease patients treated with tolvaptan
MA Anderegg, NA Dhayat, G Sommer, M Semmo… - Kidney medicine, 2020 - Elsevier
Rationale & Objective The impact of tolvaptan on health-related quality-of-life (HRQoL) in
patients with autosomal dominant polycystic kidney disease (ADPKD) is unknown. To …
patients with autosomal dominant polycystic kidney disease (ADPKD) is unknown. To …
[PDF][PDF] KHA-CARI guideline recommendations for the diagnosis and management of autosomal dominant polycystic kidney disease
GK Rangan, SI Alexander, KL Campbell… - Nephrology, 2016 - researchgate.net
KHA-CARI guideline recommendations for the diagnosis and management of autosomal
dominant polycystic kidney disease Page 1 This article is protected by copyright. All rights …
dominant polycystic kidney disease Page 1 This article is protected by copyright. All rights …
The relationship between depression, anxiety, quality of life levels, and the chronic kidney disease stage in the autosomal dominant polycystic kidney disease
AM Yarlioglu, EG Oguz, AG Gundogmus… - … Urology and Nephrology, 2023 - Springer
Purpose Decreased quality of life, anxiety, depression, and other negative psychosocial
factors in autosomal dominant polycystic kidney disease (ADPKD) may lead to the patient's …
factors in autosomal dominant polycystic kidney disease (ADPKD) may lead to the patient's …
European ADPKD Forum multidisciplinary position statement on autosomal dominant polycystic kidney disease care: European ADPKD Forum and Multispecialist …
EAF co-chairs, T Harris, R Sandford… - Nephrology Dialysis …, 2018 - academic.oup.com
Autosomal dominant polycystic kidney disease (ADPKD) is a chronic, progressive condition
characterized by the development and growth of cysts in the kidneys and other organs and …
characterized by the development and growth of cysts in the kidneys and other organs and …